Walleye Capital’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Walleye Capital's TARS Position: Q3 2026 in Review
Walleye Capital sold out of Tarsus Pharmaceuticals (TARS) in Q3 2026, closing a stake of 11,906 shares — an estimated $749K sold.
Walleye Capital first reported a position in TARS in Q1 2024 and held it in 7 quarters. The position peaked at $9.9M in Q1 2024. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Walleye Capital reported no remaining Tarsus Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 11,906 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $749K.
- Walleye Capital first reported a position in Tarsus Pharmaceuticals in Q1 2024 and held it in 7 quarters.
- Walleye Capital's Tarsus Pharmaceuticals position peaked at $9.9M in Q1 2024.
- 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.